Recovering From COVID-19? Here’s All You Need To Know About The Vaccines
By Dr. Nikita Toshi +2 more
Get,
to manage your symptom
Get your,
4 Cr+ families
benefitted
OTP sent to 9988776655
You’ve successfully subscribed to receive
doctor-approved tips on Whatsapp
Get ready to feel your best.
Hi There,
Download the PharmEasy App now!!Register to Avail the Offer
Send OTPBy continuing, you agree with our Privacy Policy and Terms and Conditions
Hi There,
Sign up on PharmEasy now!!Trusted by 4 crore+ families
OTP sent to 9988776655
You have unlocked 25% off on medicines
Code: NU25
By Dr. Nikita Toshi +2 more
Covid-19 has continued relentlessly in the country and the world for the last year and a half. Currently, the nation is battling the second wave of the pandemic, with over two lakh new Covid-19 cases being registered daily in India. Though the curve for the second wave is at its declining phase now, it has left us worrying and speculating the third wave. This could mean another surge in the number of infections at the national level.
However, there is good news about the Covid-19 vaccine. More than four crore Indians have been fully vaccinated and at least nineteen crores have received their first dose. The present eligibility status for the vaccines is eighteen and above and it includes lactating mothers. Also, India has reported clotting and bleeding in just 6 out of 10 million doses of Covishield administered. So, are you a Covid-19 survivor considering whether or not to take the vaccine? Read on to find your answers.
Table of Contents
Covid vaccination is in fact strongly recommended for patients with comorbid conditions like heart disease, diabetes and kidney diseases as the impact of covid is severe in such patients, boosters are beneficial in them and elderly.
Dr. Ashish Bajaj , M.B.B.S., M.D. in Clinical Pharmacology and Toxicology
The connection between the vaccine for COVID-19 and blood clots is a highly discussed topic at present. As per a report submitted by the National AEFI (Adverse Events Following Immunisation) Committee to the Ministry of Health & Family Welfare, there is a very minuscule but definitive risk of thromboembolic events following vaccination.
Instances of bleeding and clotting stand at 0.61 for every million doses, which the committee says is in line with the expected number of diagnoses of such conditions. In fact, it is way lower than the four cases per million reported by the Medical and Health Regulatory Authority (MHRA) of the United Kingdom. In preparing the report, the AEFI committee completed an in-depth case review of 498 serious and severe events, of which 26 cases have been reported to be potentially thromboembolic.
The term thromboembolic refers to the formation of a clot in a blood vessel that might also break loose and be carried by the bloodstream to plug another vessel. The complications arising from this can be life-threatening, such as heart attack or stroke. The symptoms of the condition include:
Such symptoms occur within twenty days of taking a vaccine shot, particularly of Covishield. AEFI reported that there were no potential thromboembolic events reported following the administration of the Covaxin vaccine.
However, it is also important to remember that Covishield has definite benefits in terms of preventing and reducing the severity of the infection. More than thirteen crore doses of Covishield have already been administered in the country.
It is important to take the vaccine after recovery, provided you follow the minimum waiting period of at least three months after recovery. The vaccines are safe and effective with a good immunogenic response against the Covid-19 virus. Be prudent and get your vaccine when your turn comes.
Disclaimer: The information provided here is for educational/awareness purposes only and is not intended to be a substitute for medical treatment by a healthcare professional and should not be relied upon to diagnose or treat any medical condition. The reader should consult a registered medical practitioner to determine the appropriateness of the information and before consuming any medication. PharmEasy does not provide any guarantee or warranty (express or implied) regarding the accuracy, adequacy, completeness, legality, reliability or usefulness of the information; and disclaims any liability arising thereof.
Links and product recommendations in the information provided here are advertisements of third-party products available on the website. PharmEasy does not make any representation on the accuracy or suitability of such products/services. Advertisements do not influence the editorial decisions or content. The information in this blog is subject to change without notice. The authors and administrators reserve the right to modify, add, or remove content without notification. It is your responsibility to review this disclaimer regularly for any changes.
Leave your comment...
View all comments(2)
Very useful information to the current context. Keep up the good work.
Thank you. Please stay tuned for more such articles.